WHO reported outbreak of western equine encephalitis in Argentina
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced study results that showed…
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
On Dec. 20, 2022, the United States Department of Agricultureï¾’s (USDA) National Veterinary Services Laboratory (NVSL) recently confirmed…
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
On Dec. 19, 2023, the U.S. Food and Drug Administration approved the first test that uses DNA in…
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study published in…
On Dec. 15, 2023, In a pivotal move towards addressing one of the worldï¾’s most underrecognized health challenges,…
On Dec. 14, 2023, the Department of Energyï¾’s Pacific Northwest National Laboratory announced that it had created the…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced new findings published in…
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Dec. 7, 2023, the U.S. Food and Drug Administration reported that of the more than 116 medically…
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…